Company Number: 14500984

Analysis Date: 2025-07-29 12:35 UTC

Financial Health Assessment for SKIIN LAB LTD (as at 31 October 2024)

---

1. Financial Health Score: D

Explanation:
SKIIN LAB LTD is currently showing signs of financial distress, reflected by a negative net asset position and deteriorating working capital. Despite being an active business with ongoing operations, the company’s balance sheet reveals a fragile financial state that requires urgent attention to restore stability and improve liquidity.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Fixed Assets	1,972	792	Modest increase in long-term assets, indicating some investment in equipment or fixtures.
Current Assets	6,179	6,286	Slight decrease; largely composed of debtors (£4,974) and cash (£891), showing limited cash.
Current Liabilities	23,468	18,493	Significant increase in short-term obligations, a critical red flag for liquidity risk.
Net Current Assets	-17,289	-12,207	Negative working capital, worsening by £5,082, indicating potential cash flow strain.
Total Assets less CL	-15,317	-11,415	Negative figure confirms liabilities exceed assets, a symptom of financial distress.
Net Assets / Shareholders’ Funds	-15,317	-11,415	Negative equity position, reflecting accumulated losses or undercapitalisation.
Cash Balance	891	998	Very low cash reserves relative to liabilities, pointing to tight liquidity.
Debtors	4,974	4,974	Substantial receivables, but cash conversion speed is critical for survival.
Profit and Loss Account	-15,417	-11,515	Large accumulated losses showing ongoing unprofitability or heavy investment phase.

---

3. Diagnosis: Current Financial Condition

SKIIN LAB LTD is experiencing symptoms akin to a patient with a weakened circulatory system — there is a troubling lack of "healthy cash flow." The company’s working capital is deeply negative, meaning that current liabilities vastly exceed current assets, signaling an inability to meet short-term obligations easily. The sizeable increase in current liabilities over the last year without a proportionate rise in current assets exacerbates this liquidity crunch.

The negative net asset base (£15,317) suggests the company has eroded its equity, possibly due to operational losses or insufficient capital injections. This condition is akin to a heart weakening under strain — the company’s financial foundation is compromised. Although the directors express confidence in the going concern status, the balance sheet tells a story of financial strain that could threaten operational continuity if not addressed.

The fixed asset investments show some positive signs — the company is investing in equipment or fixtures, which may be necessary for business growth. However, the very low cash reserves relative to liabilities, coupled with substantial trade debtors, raise the question of whether the company’s cash cycle is efficient enough to fund day-to-day operations and debt repayments.

---

4. Recommendations: Steps to Improve Financial Wellness

• Improve Liquidity Management:
  Focus on accelerating cash collection from debtors and consider negotiating extended payment terms with creditors to improve working capital. Tight control over cash outflows is critical to avoid insolvency risks.

• Capital Injection or Financing:
  Seek equity infusion from shareholders or external investors to restore positive net assets and provide a financial buffer. Alternatively, explore short-term financing options such as a business overdraft or invoice financing.

• Cost Control and Profitability Focus:
  Review operational costs to reduce burn rate and improve profitability. A detailed profit & loss review should identify loss-making activities or inefficiencies.

• Strategic Business Review:
  Evaluate the current business model and market strategy to ensure the company leverages growth opportunities effectively. Consider repositioning or diversification if current margins are insufficient.

• Regular Financial Monitoring:
  Implement monthly cash flow forecasts and financial KPI tracking to detect early warning signs of distress and respond proactively.

• Director Oversight and Governance:
  Given the significant financial pressures, directors should engage with financial advisors or turnaround specialists to navigate through this critical phase.

---

Summary

SKIIN LAB LTD is currently in a weakened financial state marked by negative equity and strained liquidity. The company faces serious challenges in covering its short-term liabilities, signaling a need for immediate financial and operational intervention. With focused efforts on cash flow improvement, capital reinforcement, and cost management, there is potential to stabilize and improve the company’s financial health.

---